Verastem Inc. Secures FDA Accelerated Approval for Breakthrough Ovarian Cancer Therapy
Verastem Inc. has received accelerated FDA approval for its innovative ovarian cancer therapy, AVMAPKI FAKZYNJA, marking a significant milestone in the company’s mission to advance new medicines for cancer treatment.
3 minutes to read